Genertec Universal Medical Group Company Limited (02666.HK) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	28.5B	14.5B	13.7B	13.7B	11.6B
Cost of Revenue	5.0B	9.6B	9.1B	9.1B	7.6B
Gross Profit	23.5B	5.1B	4.6B	4.6B	11.7B
Operating Expenses
R&D Expense	152.8M	77.7M	66.8M	35.9M	48.1M
SG&A Expense	3.6B	1.8B	1.7B	1.6B	1.4B
General & Admin Expense	2.9B	1.4B	1.3B	1.2B	899.2M
Selling & Marketing Expense	713.4M	362.4M	375.4M	397.2M	441.6M
Other Expenses	(364.7M)	(1.3B)	(271.0M)	(225.6M)	(256.7M)
Total Operating Expenses	3.4B	552.7M	1.5B	1.3B	1.1B
Cost and Expenses	8.4B	1.9B	10.6B	10.4B	8.9B
Operating Income (EBIT)	16.0B	12.7B	3.1B	3.2B	10.3B
Non-Operating
Interest Income	4.9B	41.9M	55.5M	84.1M	74.0M
Interest Expense	729.3M	69.3M	50.7M	39.1M	35.3M
Net Interest Income	4.1B	(27.4M)	4.8M	45.1M	38.5M
Other Non-Op Income/Expense	(14.1B)	(9.6B)	(179.7M)	(365.6M)	(644.1M)
Non-Operating Income (excl Interest)	337.0M	(87.8M)	129.0M	326.6M	608.5M
EBT (Pre-Tax Income)	6.0B	3.0B	2.9B	2.9B	2.7B
Income Tax Expense	1.4B	701.6M	648.8M	667.1M	616.8M
Bottom Line
Net Income	4.4B	2.2B	2.1B	2.1B	2.0B
Earnings from Cont. Ops	4.7B	2.3B	2.3B	2.2B	2.1B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	4.3B	2.2B	2.0B	2.0B	1.9B
Per Share
Basic EPS	HK$2.14	HK$1.08	HK$1.07	HK$0.97	HK$1.00
Diluted EPS	HK$2.14	HK$1.08	HK$1.02	HK$0.97	HK$0.93
Revenue Per Share	HK$14.13	HK$7.22	HK$7.22	HK$6.55	HK$5.68
Shares
Basic Shares Outstanding	2.0B	2.0B	1.9B	2.1B	2.0B
Diluted Shares Outstanding	2.0B	2.0B	2.0B	2.1B	2.1B
Profitability Metrics
EBITDA	253.2M	3.9B	3.6B	3.4B	3.2B
D&A	1.9B	788.5M	602.3M	508.7M	442.0M
EBIT	(2.8B)	3.1B	3.0B	2.9B	2.7B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026